Follow WOWNEWS 24x7 on:
Updated: July 25, 2025 20:25
RPG Life Sciences Ltd posted robust financial performance for the quarter ended June 2025 (Q1 FY2026), showcasing strong profit growth, improved margins, and a renewed focus on innovation and capacity building.
Key Financial Highlights:
Profit After Tax grew to ₹262.9 million, up about 21% year-on-year, reflecting operational efficiency and top-line momentum.
Revenue from operations rose to ₹1.69 billion, up nearly 12% YoY.
The company reported strong sequential growth in profitability compared to the previous quarter.
Operational Updates & Management Commentary
Modernization Initiatives: Significant capital expenditure is underway to upgrade API and formulations plants. R&D laboratories have been modernized, focusing on a “smart product pipeline.”
Business Segment Growth: International formulations continued double-digit revenue growth. API business also performed robustly this quarter.
Future Outlook: The management reaffirmed ambitions for new product launches and global expansion.
Key Highlights
Robust revenue and profit surge amid challenging market conditions.
Ongoing investments in technology, facility modernization, and R&D pipeline.
Focused strategy to expand international and API segments.
Management optimistic on sustaining growth trajectory and value creation.
Source:
Reuters, TradingView, and company results
Follow WOWNEWS 24x7 on:
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
